Germany-based Insightec and Israel-based Siemens Healthineers entered into a strategic agreement to develop compatibility between Insightec's Exablate Neuro device and Siemans' clinical MRI systems.

Please provide your email address to receive an email when new articles are posted on . The FDA has granted approval to Insightec for Exablate Neuro, a new device for treating patients with advanced ...

HAIFA, Israel and WAUKESHA, Wisconsin, July 10, 2019 /PRNewswire/ -- GE Healthcare, a leader in medical technology and diagnostic and therapeutic imaging, and INSIGHTEC®, a global medical technology ...

Insightec Ltd. received U.S. FDA approval for use of its Exablate Neuro device to address severe motor symptoms in patients with Parkinson’s disease, offering a new option for patients who have not ...

Exablate neuro device Patients are awake and responsive during the whole treatment duration. The Food and Drug Administration (FDA) has expanded the approval of Exablate ® Neuro to include treatment ...